Literature DB >> 9763071

Laser therapy of squamous cell dysplasia and carcinoma of the penis.

D N Tietjen1, R S Malek.   

Abstract

OBJECTIVES: To analyze the influence of etiologic factors and practical issues regarding the merits, limitations, and long-term results of aggressive laser treatment of premalignant and malignant squamous cell lesions of the penis.
METHODS: Preparation of genital skin with 5% acetic acid and mapping biopsies of lesions and the surrounding field-of-change were performed in 52 men evaluated and subsequently treated with laser during a 10-year period. Most men (81%) were or had been smokers, and many (46%) had female sexual partners infected with human papillomavirus. Carbon dioxide laser was used for low-stage lesions; potassium-titanylphosphate/532 or neodymium:yttrium-aluminum-garnet laser was used for more histologically advanced lesions. Not only the lesions but also the entire human papillomavirus-induced field-of-change was treated. Circumcision was performed simultaneously in 28 previously uncircumcised patients.
RESULTS: All lesions demonstrated aceto-whitening and histologic changes of human papillomavirus infection. Human papillomavirus DNA was detected in 93.5% of the specimens from 31 patients studied. Of the 52 patients, 22 (42%) had dysplastic premalignant penile intraepithelial neoplasia, and the remaining 30 (58%) had squamous cell carcinoma. Forty-four patients were available for follow-up from 12 to 117 months (average 58). Overall, 5 patients (11.4%) experienced a recurrence: 3 were successfully re-treated with laser, and 2 patients underwent partial penectomy, 1 of whom with squamous cell carcinoma Stage T2 died of metastatic disease.
CONCLUSIONS: Aggressive laser therapy of the visible lesions and of the entire dysplastic premalignant field-of-change produces excellent cosmetic results. The entire penis and, therefore, its full sexual functional potential are preserved. The low rate of local recurrence over the long term in all but deeply invasive (T2) lesions compares favorably with the outcome of other, more conventional therapies. Irrespective of therapeutic approach, close and long-term surveillance of all patients and counseling for their sexual partners are mandatory.

Entities:  

Mesh:

Year:  1998        PMID: 9763071     DOI: 10.1016/s0090-4295(98)00308-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Diagnosis and management of premalignant penile lesions.

Authors:  Majid Shabbir; Suks Minhas; Asif Muneer
Journal:  Ther Adv Urol       Date:  2011-06

Review 2.  What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes.

Authors:  Vasileios I Sakalis; Riccardo Campi; Lenka Barreto; Herney Garcia Perdomo; Isabella Greco; Łukasz Zapala; Mithun Kailavasan; Tiago Antunes-Lopes; Jack David Marcus; Kenneth Manzie; John Osborne; Benjamin Ayres; Luc M F Moonen; Andrea Necchi; Juanita Crook; Pedro Oliveira; Lance C Pagliaro; Chris Protzel; Arie S Parnham; Maarten Albersen; Curtis A Pettaway; Philippe E Spiess; Scott T Tagawa; R Bryan Rumble; Oscar R Brouwer
Journal:  Eur Urol Open Sci       Date:  2022-05-02

3.  [Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery].

Authors:  M Angerer-Shpilenya; N T Gaisa; G Jakse
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

4.  Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Authors:  Gennaro Musi; Andrea Russo; Andrea Conti; Francesco A Mistretta; Ettore Di Trapani; Stefano Luzzago; Roberto Bianchi; Giuseppe Renne; Stefano Ramoni; Matteo Ferro; Deliu Victor Matei; Marco Cusini; Luca Carmignani; Ottavio de Cobelli
Journal:  World J Urol       Date:  2017-12-02       Impact factor: 4.226

Review 5.  Contemporary role of radiotherapy in the management of penile cancer.

Authors:  Martin Arthur Korzeniowski; Juanita Mary Crook
Journal:  Transl Androl Urol       Date:  2017-10

Review 6.  Penile sparing surgical approaches for primary penile tumors: preserving function and appearance.

Authors:  Adam S Baumgarten; John S Fisher; Samuel M Lawindy; Jonathan G Pavlinec; Rafael E Carrion; Philippe E Spiess
Journal:  Transl Androl Urol       Date:  2017-10

Review 7.  Penile-sparing modalities in the management of low-stage penile cancer.

Authors:  Paurush Babbar; Nitin Yerram; Alice Crane; Daniel Sun; Kyle Ericson; Andrew Sun; Abhinav Khanna; Hadley Wood; Andrew Stephenson; Kenneth Angermeier
Journal:  Urol Ann       Date:  2018 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.